IMV INC

IMV Inc Inc. applies its novel adjuvanting platform to the development of vaccines for cancer therapy, infectious diseases and animal health. The Company’s DepoVax™ platform is a patented formulation that provides controlled and prolonged exposure of antigens plus adjuvant to the immune system. IMV Inc has advanced two DepoVax-based cancer vaccines into Phase I human clinical trials. The Company is also advancing a broad infectious disease pipeline including vaccines in such indications as malaria, respiratory syncytial virus (RSV) and anthrax. In addition to the Company’s human health vaccine strategy, it continues to capture value from animal health vaccine applications. IMV Inc has key partnerships in the animal health sector including an agreement with Pfizer Animal Health.

#People #Financial #Event #Website #More

IMV INC

Social Links:

Facebook

Twitter

Youtube

Industry:

Biotechnology Health Diagnostics Therapeutics

Founded:

2000-01-01

Address:

Halifax, Nova Scotia, Canada

Country:

Canada

Website Url:

http://www.imvaccine.com

Total Employee:

11+

Status:

Active

Contact:

19024920888

Email Addresses:

[email protected]

Total Funding:

71.16 M USD

Technology used in webpage:

SPF Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS GoDaddy RapidSSL Akamai Hosted Campaign Monitor Widget

Current Advisors List

michael-p-bailey_image

Michael P. Bailey Board Member @ IMV Inc
Board_member
2020-07-01

julia-gregory_image

Julia Gregory Member of the Board of Directors, Compensation Committee member @ IMV Inc
Board_member
2018-06-01

Founder

brian-lowe_image

Brian Lowe

Stock Details

Company's stock symbol is CVE:IMV

Investors List

horizon-technology-finance_image

Key Employee Changes

Date	New article
2021-06-09	IMV Announces Appointment of Jeremy R. Graff, Ph.D. as Chief Scientific Officer And Addition of Clinical Advisor

Official Site Inspections

http://www.imvaccine.com

Host Informations
Whois Informations

Loading ...